JP6115801B2 - 腺癌の検出のための蛋白質シグネチャー／マーカー - Google Patents

腺癌の検出のための蛋白質シグネチャー／マーカー Download PDF

Info

Publication number
JP6115801B2
JP6115801B2 JP2010500358A JP2010500358A JP6115801B2 JP 6115801 B2 JP6115801 B2 JP 6115801B2 JP 2010500358 A JP2010500358 A JP 2010500358A JP 2010500358 A JP2010500358 A JP 2010500358A JP 6115801 B2 JP6115801 B2 JP 6115801B2
Authority
JP
Japan
Prior art keywords
antibody
proteins
array
binding
binding agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010500358A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010522875A (ja
JP2010522875A5 (enExample
Inventor
カール・アーネ・クリステル・ボレベック
ラルス・ベルティル・クリステル・ヴィングレン
Original Assignee
イミュノヴィア・アーベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0705876A external-priority patent/GB0705876D0/en
Priority claimed from GB0712181A external-priority patent/GB0712181D0/en
Application filed by イミュノヴィア・アーベー filed Critical イミュノヴィア・アーベー
Publication of JP2010522875A publication Critical patent/JP2010522875A/ja
Publication of JP2010522875A5 publication Critical patent/JP2010522875A5/ja
Application granted granted Critical
Publication of JP6115801B2 publication Critical patent/JP6115801B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/57525—
    • G01N33/5758—

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
JP2010500358A 2007-03-27 2008-03-25 腺癌の検出のための蛋白質シグネチャー／マーカー Expired - Fee Related JP6115801B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0705876A GB0705876D0 (en) 2007-03-27 2007-03-27 Method, array and use thereof
GB0705876.1 2007-03-27
GB0712181.7 2007-06-25
GB0712181A GB0712181D0 (en) 2007-06-25 2007-06-25 Method, array and use thereof
PCT/GB2008/001090 WO2008117067A2 (en) 2007-03-27 2008-03-25 Protein signature/markers for the detection of adenocarcinoma

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015108468A Division JP2015187611A (ja) 2007-03-27 2015-05-28 腺癌の検出のための蛋白質シグネチャー／マーカー

Publications (3)

Publication Number Publication Date
JP2010522875A JP2010522875A (ja) 2010-07-08
JP2010522875A5 JP2010522875A5 (enExample) 2011-05-12
JP6115801B2 true JP6115801B2 (ja) 2017-04-19

Family

ID=39493874

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010500358A Expired - Fee Related JP6115801B2 (ja) 2007-03-27 2008-03-25 腺癌の検出のための蛋白質シグネチャー／マーカー
JP2015108468A Pending JP2015187611A (ja) 2007-03-27 2015-05-28 腺癌の検出のための蛋白質シグネチャー／マーカー
JP2017000956A Expired - Fee Related JP6465902B2 (ja) 2007-03-27 2017-01-06 腺癌の検出のための蛋白質シグネチャー／マーカー

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015108468A Pending JP2015187611A (ja) 2007-03-27 2015-05-28 腺癌の検出のための蛋白質シグネチャー／マーカー
JP2017000956A Expired - Fee Related JP6465902B2 (ja) 2007-03-27 2017-01-06 腺癌の検出のための蛋白質シグネチャー／マーカー

Country Status (10)

Country Link
US (3) US20100105571A1 (enExample)
EP (3) EP2490025A3 (enExample)
JP (3) JP6115801B2 (enExample)
CN (2) CN101680896A (enExample)
AU (3) AU2008231575A1 (enExample)
CA (1) CA2681899C (enExample)
DK (1) DK2140269T3 (enExample)
ES (1) ES2442919T3 (enExample)
PL (1) PL2140269T3 (enExample)
WO (1) WO2008117067A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101680896A (zh) 2007-03-27 2010-03-24 伊缪诺维亚公司 检测腺癌的蛋白标志/标记
GB0723179D0 (en) * 2007-11-27 2008-01-02 Immunovia Ab Diagnostic methods and arrays for use in the same
US10359425B2 (en) 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
EP2415877A3 (en) * 2010-02-17 2012-02-15 Deutsches Krebsforschungszentrum Means and methods for diagnosing pancreatic cancer
GB201009798D0 (en) 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
BR112012032537B8 (pt) 2010-07-09 2022-10-18 Somalogic Inc Métodos para diagnosticar se um indivíduo tem ou não câncer de pulmão de não pequenas células, ou para fornecer informações sobre câncer de pulmão de não pequenas células em um indivíduo
MX350533B (es) 2010-08-13 2017-09-08 Somalogic Inc Biomarcadores de cancer pancreatico y usos de los mismos.
GB201103726D0 (en) * 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
KR20150129932A (ko) 2014-05-12 2015-11-23 연세대학교 산학협력단 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트
GB201516801D0 (en) 2015-09-22 2015-11-04 Immunovia Ab Method, array and use thereof
RU2627448C1 (ru) * 2016-04-05 2017-08-08 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Способ иммуногистохимического выявления антигенов в препаратах органов продуктивных и непродуктивных животных длительного хранения в фиксаторах
GB201608192D0 (en) 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
GB201701572D0 (en) 2017-01-31 2017-03-15 Immunovia Ab Methods, arrays and uses thereof
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12586T1 (de) 1980-05-02 1985-04-15 Edward P Davis Beinentlastungsgeraet.
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
CA1202235A (en) * 1983-08-30 1986-03-25 Paul S. Satoh Immunoassay for complement fragments
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
GB9704444D0 (en) * 1997-03-04 1997-04-23 Isis Innovation Non-invasive prenatal diagnosis
US6355623B2 (en) * 1998-09-24 2002-03-12 Hopital-Sainte-Justine Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage
EP1153301A1 (en) 1999-02-19 2001-11-14 University Of Iowa Research Foundation Diagnostics and therapeutics for arterial wall disruptive disorders
EP2277542B1 (en) 2001-06-01 2014-04-16 Cornell Research Foundation Inc. Modified antibodies to prostrate-specific membrane antigen and uses thereof
US20050260639A1 (en) * 2002-09-30 2005-11-24 Oncotherapy Science, Inc. Method for diagnosing pancreatic cancer
CA2500472A1 (en) 2002-09-30 2004-04-15 Oncotherapy Science, Inc. Genes and polypeptides relating to human pancreatic cancers
DE60325541D1 (de) 2002-10-31 2009-02-12 Hoffmann La Roche Verfahren/Präparat zur Erkennung von Pankreaskrebs
US20040219572A1 (en) * 2002-12-17 2004-11-04 Jie Chen Specific markers for pancreatic cancer
JP3857241B2 (ja) * 2003-02-17 2006-12-13 スパンション インク 昇圧電源の振幅を小さくしたチャージポンプ回路
JP4194080B2 (ja) * 2003-02-19 2008-12-10 茂 森村 膵癌検出用マーカー
KR20110094361A (ko) 2003-04-11 2011-08-23 메디뮨 엘엘씨 재조합 ｉｌ­９ 항체 및 그의 용도
US20040248205A1 (en) * 2003-04-16 2004-12-09 Stern Lawrence J. Major histocompatibility complex (MHC)-peptide arrays
US20050095611A1 (en) 2003-05-02 2005-05-05 Chan Daniel W. Identification of biomarkers for detecting pancreatic cancer
EP1638510B1 (en) 2003-07-01 2015-09-02 Immunomedics, Inc. Multivalent carriers of bi-specific antibodies
CA2531916A1 (en) * 2003-07-10 2005-02-17 Central Institute For Experimental Animals Animal model for the analysis of tumor metastasis
US20050277137A1 (en) * 2003-08-15 2005-12-15 University Of Pittsburgh Diagnostic multimarker serological profiling
ATE437179T1 (de) * 2003-12-24 2009-08-15 Merck Serono Sa Cc-chemokin-bindende zeckenproteine
US20060106119A1 (en) * 2004-01-12 2006-05-18 Chang-Jie Guo Novel integration for CO and H2 recovery in gas to liquid processes
BRPI0511624B1 (pt) 2004-05-28 2022-02-08 Agensys, Inc Anticorpo monoclonal que se liga à proteína psca, uso do mesmo, hibridoma, vetor, composição farmacêutica, bem como ensaio e método para detecção da presença de uma proteína psca em uma amostra biológica
US8383357B2 (en) 2005-03-16 2013-02-26 OSI Pharmaceuticals, LLC Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
EP1865981A2 (en) * 2005-04-07 2007-12-19 Chiron Corporation Cacna1e in cancer diagnosis, detection and treatment
WO2006110581A2 (en) 2005-04-07 2006-10-19 Novartis Vaccines And Diagnostics Inc. Cancer-related genes
US8632983B2 (en) 2005-04-15 2014-01-21 Van Andel Research Institute Biomarkers for pancreatic cancer and diagnostic methods
CN1851455B (zh) 2005-04-22 2010-11-10 复旦大学附属中山医院 一种肿瘤标志物-血清蛋白指纹图谱的检测方法
EP3578985B1 (en) * 2005-05-05 2021-01-13 Drexel University Diagnosis of liver pathology through assessment of protein glycosylation
EP1736780A1 (en) * 2005-06-24 2006-12-27 Eppendorf Array Technologies S.A. Method and means for detecting and/or quantifying hierarchical molecular change of a cell in response to an external stimulus
JP2007051880A (ja) * 2005-08-15 2007-03-01 Tokyo Univ Of Science 膵臓癌の検出方法、膵臓癌の診断キット
WO2007082099A2 (en) 2006-01-11 2007-07-19 Genomic Health, Inc. Gene expression markers for colorectal cancer prognosis
WO2007107774A2 (en) 2006-03-22 2007-09-27 Cartela R & D Ab Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer
WO2007122820A1 (ja) 2006-04-18 2007-11-01 Perseus Proteomics Inc. 膵臓癌の診断薬及び治療薬
US20080038301A1 (en) 2006-08-08 2008-02-14 The Procter & Gamble Company Personal care product comprising collapsible water-containing capsules
KR100819122B1 (ko) 2006-09-30 2008-04-04 남명진 췌장암 진단용 키트
RU2473555C2 (ru) * 2006-12-19 2013-01-27 ДжинГоу, Инк. Новые способы функционального анализа большого количества экспериментальных данных и групп генов, идентифицированных из указанных данных
CN101246176B (zh) 2007-02-13 2013-06-05 许洋 鳞状细胞癌抗原阴性宫颈癌血清蛋白质检测的质谱试剂及其制备方法
CN101680896A (zh) 2007-03-27 2010-03-24 伊缪诺维亚公司 检测腺癌的蛋白标志/标记
GB0709092D0 (en) 2007-05-11 2007-06-20 Borrebaeck Carl Diagnosis and method of disease
NZ555363A (en) 2007-05-24 2009-11-27 Pacific Edge Biotechnology Ltd Prognosis prediction for melanoma cancer
EP2637020A3 (en) 2007-06-29 2014-01-08 Correlogic Systems Inc. Predictive markers for ovarian cancer
EP2217625B1 (en) 2007-11-08 2021-08-04 Precision Biologics, Inc. Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
GB0723179D0 (en) 2007-11-27 2008-01-02 Immunovia Ab Diagnostic methods and arrays for use in the same
JP2011516826A (ja) 2008-03-07 2011-05-26 オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド 間葉系様腫瘍細胞またはこの形成を阻害する作用剤の同定のための方法
GB0815846D0 (en) 2008-09-01 2008-10-08 Immunovia Ab diagnosis, prognosis and imaging of disease
CN101676300B (zh) 2008-09-16 2012-05-02 中国科学院生物物理研究所 一种抑制人结肠肿瘤生长的新型抗体及其在制备用于早期诊断结直肠癌、子宫内膜癌以及胰腺癌的诊断剂中的应用
CN101451975B (zh) 2008-12-29 2012-01-25 浙江大学 一种检测胃癌预后与分期血清蛋白质的方法
US20120004289A1 (en) 2009-03-06 2012-01-05 The Johns Hopkins University Annexin a11 and associated genes as biomarkers for cancer
EP3257953B1 (en) 2009-03-12 2018-09-26 Cancer Prevention And Cure, Ltd. Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy
CN101880707A (zh) 2009-05-05 2010-11-10 中国人民解放军第二军医大学 microRNA-21在鉴别胰腺癌中的应用
CN101613748A (zh) 2009-06-09 2009-12-30 中国人民解放军第二军医大学 一种检测胰腺癌血清标志物的方法
RU2421149C2 (ru) 2009-07-16 2011-06-20 Ольга Васильевна Кокуева Способ дифференциальной диагностики рака поджелудочной железы и хронического панкреатита
SG168431A1 (en) 2009-07-23 2011-02-28 Univ Singapore Cancer biomarker and the use thereof
WO2011039289A1 (de) 2009-09-29 2011-04-07 Protagen Ag Markersequenzen für pankreaskrebserkrankungen, pankreaskarzinom und deren verwendung
CN102279264A (zh) 2010-06-09 2011-12-14 李彬 48种恶性肿瘤标志物抗体芯片的制备方法
WO2012021407A2 (en) 2010-08-13 2012-02-16 Morehouse School Of Medicine Biomarkers for stroke
WO2012031374A1 (zh) 2010-09-09 2012-03-15 北京同为时代生物技术有限公司 用于诊断上皮源性癌症的血液标志物及其单克隆抗体
GB201103726D0 (en) 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
CN102201038B (zh) 2011-04-27 2013-06-05 浙江大学 脑瘤p53蛋白表达检测方法
CN102286464B (zh) 2011-06-30 2013-07-17 眭维国 尿毒症长链非编码核糖核酸差异性表达图谱模型及其构建方法
WO2013052480A1 (en) 2011-10-03 2013-04-11 The Board Of Regents Of The University Of Texas System Marker-based prognostic risk score in colon cancer
US20150018235A1 (en) 2012-01-13 2015-01-15 Oncocyte Corporation Methods and Compositions for the Treatment and Diagnosis of Pancreatic Cancer
CA2893745A1 (en) 2012-12-04 2014-06-12 Caris Mpi, Inc. Molecular profiling for cancer
TWI658049B (zh) 2013-03-12 2019-05-01 腫瘤療法 科學股份有限公司 Ｋｎｔｃ２胜肽及含此胜肽之疫苗
CA2902841A1 (en) 2013-03-13 2014-10-02 Creatics Llc Methods and compositions for detecting pancreatic cancer
CA2904973A1 (en) 2013-03-15 2014-09-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Ratio based biomarkers and methods of use thereof
JP6683986B2 (ja) 2013-07-10 2020-04-22 国立大学法人 東京大学 がん幹細胞分子マーカー
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
WO2015112429A1 (en) 2014-01-23 2015-07-30 Newomics Inc Methods and systems for diagnosing diseases
WO2015157557A1 (en) 2014-04-09 2015-10-15 Myriad Rbm, Inc. Methods of diagnosing pancreatic cancer and methods related thereto
US10451628B2 (en) 2014-05-07 2019-10-22 University Of Utah Research Foundation Biomarkers and methods for diagnosis of early stage pancreatic ductal adenocarcinoma
KR20150129932A (ko) 2014-05-12 2015-11-23 연세대학교 산학협력단 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트
GB201501930D0 (en) 2015-02-05 2015-03-25 Univ London Queen Mary Biomarkers for pancreatic cancer
CN105092845A (zh) 2015-07-10 2015-11-25 深圳市贝沃德克生物技术研究院有限公司 胰腺癌蛋白生物标记物、用途及其检测芯片和检测装置
CN105092844A (zh) 2015-07-10 2015-11-25 深圳市贝沃德克生物技术研究院有限公司 胰腺癌蛋白生物标记物的检测试剂盒及检测系统
GB201516801D0 (en) 2015-09-22 2015-11-04 Immunovia Ab Method, array and use thereof
GB201608192D0 (en) * 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
GB201701572D0 (en) * 2017-01-31 2017-03-15 Immunovia Ab Methods, arrays and uses thereof
WO2019232361A1 (en) 2018-05-31 2019-12-05 University Of Florida Research Foundation Personalized treatment of pancreatic cancer
CN111171053B (zh) 2020-01-06 2021-03-05 丽水市中心医院 一种化合物在制备治疗胰腺癌药物中的应用
GB202010970D0 (en) * 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof

Also Published As

Publication number Publication date
EP2140269A2 (en) 2010-01-06
US20170307620A1 (en) 2017-10-26
EP2490025A2 (en) 2012-08-22
AU2008231575A1 (en) 2008-10-02
EP3851856A2 (en) 2021-07-21
WO2008117067A8 (en) 2009-04-16
US20100105571A1 (en) 2010-04-29
WO2008117067A3 (en) 2008-11-20
US11525832B2 (en) 2022-12-13
DK2140269T3 (da) 2013-12-16
JP2017067792A (ja) 2017-04-06
JP2015187611A (ja) 2015-10-29
CN101680896A (zh) 2010-03-24
AU2014204510A1 (en) 2014-08-07
CA2681899A1 (en) 2008-10-02
JP2010522875A (ja) 2010-07-08
EP3851856A3 (en) 2021-11-03
ES2442919T3 (es) 2014-02-14
JP6465902B2 (ja) 2019-02-06
PL2140269T3 (pl) 2014-07-31
US20200018760A1 (en) 2020-01-16
EP2490025A3 (en) 2012-11-28
CN107102142A (zh) 2017-08-29
CA2681899C (en) 2018-06-19
AU2016238939A1 (en) 2016-11-03
AU2014204510C1 (en) 2017-01-19
AU2016238939B2 (en) 2018-08-02
EP2140269B1 (en) 2013-11-20
AU2014204510B2 (en) 2016-10-27
WO2008117067A9 (en) 2008-12-31
WO2008117067A2 (en) 2008-10-02

Similar Documents

Publication Publication Date Title
JP6465902B2 (ja) 腺癌の検出のための蛋白質シグネチャー／マーカー
US20200088742A1 (en) Method, array and use for determining the presence of pancreatic cancer
US20100304979A1 (en) Diagnostic Methods and Arrays for Use in the Same
CN105917230A (zh) 用于确定胰腺癌的方法、阵列和其用途
JP6104796B2 (ja) 方法、アレイ、およびこれらの使用
CN105283763B (zh) 用于前列腺癌的生物标志物检测中的方法和阵列
HK1142674A (en) Protein signature/markers for the detection of adenocarcinoma

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110325

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110325

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120323

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120711

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121127

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130221

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130228

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130523

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140217

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140515

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140522

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140815

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150528

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20150604

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20150904

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160426

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160701

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160729

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170113

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170309

R150 Certificate of patent or registration of utility model

Ref document number: 6115801

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees